Glenview Trust’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-851,541
Closed -$21.5M 496
2025
Q3
$21.5M Sell
851,541
-48,144
-5% -$1.21M 0.34% 61
2025
Q2
$22.7M Sell
899,685
-33,974
-4% -$853K 0.39% 56
2025
Q1
$23.5M Buy
933,659
+211
+0% +$5.3K 0.46% 52
2024
Q4
$23.4M Buy
933,448
+115,711
+14% +$2.9M 0.44% 53
2024
Q3
$20.5M Buy
817,737
+6,005
+0.7% +$150K 0.39% 60
2024
Q2
$20.2M Buy
811,732
+57,465
+8% +$1.42M 0.41% 59
2024
Q1
$18.7M Buy
754,267
+93,927
+14% +$2.33M 0.4% 66
2023
Q4
$16.4M Buy
660,340
+147,990
+29% +$3.63M 0.4% 65
2023
Q3
$12.5M Buy
512,350
+91,874
+22% +$2.24M 0.34% 77
2023
Q2
$10.3M Buy
420,476
+59,590
+17% +$1.46M 0.28% 85
2023
Q1
$8.85M Buy
360,886
+178,200
+98% +$4.35M 0.27% 93
2022
Q4
$4.44M Buy
+182,686
New +$4.43M 0.15% 116

Other funds holding IBDQ

Glenview Trust's IBDQ Position: Q4 2025 in Review

Glenview Trust sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 851,541 shares — an estimated $21.5M sold.

Glenview Trust first reported a position in IBDQ in Q4 2022 and held it in 12 quarters. The position peaked at $23.5M in Q1 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Glenview Trust reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Glenview Trust sold 851,541 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $21.5M.
  • Glenview Trust first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2022 and held it in 12 quarters.
  • Glenview Trust's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $23.5M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Glenview Trust's 13F filing for Q4 2025, filed 9 Feb 2026.